VirtECS® for Biologics Manufacturers

A planning & scheduling tool uniquely designed to optimize production of drug product and substance 

From upstream operations to downstream purification, VirtECS® is designed to handle the full scope of bulk manufacturing while addressing the most challenging production constraints.

After years of R&D development, VirtECS® software is now used by leading biologics manufacturers across the globe. 

The manufacture of biologics is similar to other processes in many ways, including certain production steps and the style of equipment, but there are also unique challenges to the clinical manufacturing of drug product and substance. VirtECS® provides flexibility, shared resource coordination, solution storage and many other features that address the specific needs of biologics manufacturers.

At each step, VirtECS® ensures schedule feasibility, prevents overlooked conflicts and maximizes utilization of all lines. 

IN THIS GUIDE, YOU’LL LEARN:

W

How VirtECS® caters specifically to biologics manufacturers. 

W

The customization options available within the planning & scheduling platform.

W

VirtECS® abilities that minimize manual labor and the number of errors made during scheduling. 

W

How VirtECS® Symphony facilitates feedback between users and allows for schedule changes in real time.

RECENT NEWS & INSIGHT

The Pros & Cons of Internal Facilities and CDMOs for Biopharmaceutical Companies

For years, many of the leaders in the biopharmaceutical industry focused on vertical integration in their supply chain. These industry giants built an internal network of manufacturing plants to keep the production of drug substance and drug product under their...

How Contract Manufacturers Can Use a Digital Twin to Overcome Slowing Demand Post-Pandemic

During the heights of the Covid-19 pandemic, contract development and manufacturing organizations, or CDMOs, experienced a historic surge in demand. Large pharmaceutical companies had raced to create vaccines and treatments, but once they were approved, those...

Case Study: How A Biologics Company Uses a Digital Twin to Analyze Facility Fit

When we talk to biologics companies about implementing VirtECS at their manufacturing sites, we always ask about the planning challenges they face. In those conversations, we hear frequently about issues with facility fit and tech transfer. Many hope to cut weeks or...

Reducing Capital Investment

“Using VirtECS, we were able to debottleneck our largest production facility by identifying a sequence of changes that we never could have evaluated with a spreadsheet model. We reduced the necessary capital investment by $300 million by demonstrating areas where more equipment did not benefit throughput.”

Senior Resource Planning Manager – Biopharma Industry

Big Time Savings

“VirtECS handles all of the ripple effects to the schedule when things change. That is a big time savings in a complicated process with lots of constraints. Not to mention making sure that you don’t miss a constraint!”

Finite Scheduler – Biopharma Industry

Most Powerful Solution

“I have evaluated more than a dozen process modeling software solutions and VirtECS is hands-down the most powerful for end-to-end capacity analysis”

Director of Manufacturing Science & Technology – Leading Pharmaceutical Company

Avoid Unexpected Pitfalls

“A Discovery project with APCI helped us to identify and avoid some pitfalls that we had not anticipated. With the initial process model in place we were able to roll right into a Finite Scheduling implementation”

Product Manager – Chemical Company

An Essential Tool

“I would not want to schedule this plant without VirtECS.”

Scheduler – Leading Pharmaceutical Company